Emergence of artemisinin-resistant malaria on the Western border of Thailand: a longitudinal study

Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
The Lancet (Impact Factor: 45.22). 04/2012; 379(9830):1960-6. DOI: 10.1016/S0140-6736(12)60484-X
Source: PubMed


Artemisinin-resistant falciparum malaria has arisen in western Cambodia. A concerted international effort is underway to contain artemisinin-resistant Plasmodium falciparum, but containment strategies are dependent on whether resistance has emerged elsewhere. We aimed to establish whether artemisinin resistance has spread or emerged on the Thailand-Myanmar (Burma) border.
In malaria clinics located along the northwestern border of Thailand, we measured six hourly parasite counts in patients with uncomplicated hyperparasitaemic falciparum malaria (≥4% infected red blood cells) who had been given various oral artesunate-containing regimens since 2001. Parasite clearance half-lives were estimated and parasites were genotyped for 93 single nucleotide polymorphisms.
3202 patients were studied between 2001 and 2010. Parasite clearance half-lives lengthened from a geometric mean of 2·6 h (95% CI 2·5-2·7) in 2001, to 3·7 h (3·6-3·8) in 2010, compared with a mean of 5·5 h (5·2-5·9) in 119 patients in western Cambodia measured between 2007 and 2010. The proportion of slow-clearing infections (half-life ≥6·2 h) increased from 0·6% in 2001, to 20% in 2010, compared with 42% in western Cambodia between 2007 and 2010. Of 1583 infections genotyped, 148 multilocus parasite genotypes were identified, each of which infected between two and 13 patients. The proportion of variation in parasite clearance attributable to parasite genetics increased from 30% between 2001 and 2004, to 66% between 2007 and 2010.
Genetically determined artemisinin resistance in P falciparum emerged along the Thailand-Myanmar border at least 8 years ago and has since increased substantially. At this rate of increase, resistance will reach rates reported in western Cambodia in 2-6 years.
The Wellcome Trust and National Institutes of Health.

Download full-text


Available from: Standwell Nkhoma, Jan 05, 2014
  • Source
    • "These results were also supported by the traveling record of the studied subjects indicating their recent visits to Myanmar prior to the diagnosis and confirmation of malaria (Zhou et al., 2014). Similar situation was seen between Myanmar and Thailand where border migration played a key role in malaria epidemics in Thailand (Wiwanitkit, 2002; Zhou et al., 2005; Archavanitkul and Vajanasara, 2010; Phyo et al., 2012). Although China has demonstrated a decline in malaria morbidity and mortality, control efforts are hampered by the continuous influx of migrants with travel histories to Myanmar (Xu and Liu, 1997; Moore et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In Myanmar, civil unrest and establishment of internally displaced persons (IDP) settlement along the Myanmar-China border have impacted malaria transmission. The growing IDP populations raise deep concerns about health impact on local communities. Microsatellite markers were used to examine the source and spreading patterns of Plasmodium falciparum between IDP settlement and surrounding villages in Myanmar along the China border. Genotypic structure of P. falciparum was compared over the past three years from the same area and the demographic history was inferred to determine the source of recent infections. In addition, we examined if border migration is a factor of P. falciparum infections in China by determining gene flow patterns across borders. Compared to local community, the IDP samples showed a reduced and consistently lower genetic diversity over the past three years. A strong signature of genetic bottleneck was detected in the IDP samples. P. falciparum infections from the border regions in China were genetically similar to Myanmar and parasite gene flow was not constrained by geographical distance. Reduced genetic diversity of P. falciparum suggested intense malaria control within the IDP settlement. Human movement was a key factor to the spread of malaria both locally in Myanmar and across the international border. Copyright © 2015. Published by Elsevier B.V.
    Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 05/2015; 33. DOI:10.1016/j.meegid.2015.05.002 · 3.02 Impact Factor
  • Source
    • "Most of the cases and deaths occurred in unhygienic and developing African countries (WHO malaria report, 2013). Artemisinin combination therapy (ACTs) has been of much importance over the last decade however emergence of resistance has been reported in Cambodia's Pailin province (WHO malaria report, 2013; Phyo et al., 2012; Kumar et al., 2005) provides motivation to discover new potential antimalarial agents. More than 65 protein kinases (PKs) have been reported in the parasite kinome with ambiguous cellular target and physiological role (Nag et al., 2013a,b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The molecular modelling approach was applied to a series of nineteen curcumin analogues to find the possible PfRIO2 kinase inhibitory action. A putative active site in flexible loop (S1) of PfRIO2 kinase was explored computationally to recognize the molecular basis of ligands binding. The ligands (curcumin analogues; 3a-3s) were well accommodated in the selected active site (S1) due to their higher molecular size and length. Further all these synthesized compounds (3a-3s) were evaluated for their in vitro antimalarial activity according to the reported method. The antimalarial data showed that all these compounds to have parasitocidal activity with minimum killing concentrations (MKCs) range between 3.87 and 25.35 µM and schizontocidal activity with IC50 range between 1.48 and 23.09 µM. The compound 3p showed the most significant result with maximum schizontocidal (IC50; 1.48±0.10 µM) and parasitocidal activities (MKC; 3.87±0.36 µM) could be identified as promising lead for further investigations.
    Arabian Journal of Chemistry 04/2015; 2013. DOI:10.1016/j.arabjc.2015.04.011 · 3.73 Impact Factor
  • Source
    • "However, a delayed-clearance phenotype has already been reported both in western Cambodia (Dondorp et al., 2010) and Thailand (Phyo et al., 2012). This delayed-clearance phenotype, whilst not of clinical significance yet (Phyo et al., 2012), is the first indication that resistance to artemisinin may emerge soon. This has important implications for global eradication efforts, as it will likely be at least a decade before a new compound is capable of replacing the artemisinins (Olliaro et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Owing to the implementation of a national malaria elimination programme from 2010 to 2020, we performed a systematic review to assess research challenges in the People's Republic of China (P.R. China) and define research priorities in the next few years. A systematic search was conducted for articles published from January 2000 to December 2012 in international journals from PubMed and Chinese journals from the China National Knowledge Infrastructure (CNKI). In total, 2532 articles from CNKI and 308 articles from PubMed published between 2010 and 2012 related to malaria after unrelated references and review or comment were further excluded, and a set of research gaps have been identified that could hinder progress toward malaria elimination in P.R. China. For example, there is a lack of sensitive and specific tests for the diagnosis of malaria cases with low parasitemia, and there is a need for surveillance tools that can evaluate the epidemic status for guiding the elimination strategy. Hence, we argue that malaria elimination will be accelerated in P.R. China through the development of new tests, such as detection of parasite or drug resistance, monitoring glucose-6-phosphate dehydrogenase (G6PD) deficiency, active malaria screening methods, and understanding the effects of the environment and climate variation on vector distribution. Copyright © 2014 Elsevier Ltd. All rights reserved.
    Advances in Parasitology 12/2014; 86:109-33. DOI:10.1016/B978-0-12-800869-0.00005-6 · 6.23 Impact Factor
Show more